Skip to main content

Year: 2025

Vireo Growth Inc. Announces Third Quarter 2025 Results

Q3 GAAP revenue of $91.7 million increased 264% year-over-year, driven by recently closed M&A transactions and organic growth throughout the portfolio Completed refinancing of senior secured debt which is expected to decrease annualized interest expense by $10 million Closed Q3 with $117 million in cash; expects to remain acquisitive in distressed environment MINNEAPOLIS, Nov. 12, 2025 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today reported financial results for its third fiscal quarter ended September 30, 2025. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency figures referenced herein are denominated in U.S. dollars. Summary...

Continue reading

Ocean Power Technologies and Mythos AI Partner to Advance Autonomous Maritime Capabilities

MONROE TOWNSHIP, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT), a leader in intelligent maritime systems and ocean energy solutions, today announced a partnership with Mythos AI to integrate advanced AI-driven autonomy software across OPT’s fleet of WAM-V® Autonomous Surface Vehicles (ASVs) and PowerBuoy® platforms. This collaboration is designed to enhance OPT’s operational capabilities and accelerate the range of integrated solutions the company can deliver to customers in defense, security, and commercial sectors while expanding OPT’s addressable market by strengthening its position in the fast growing autonomous and intelligent systems domain. OPT believes that the combination of OPT’s proven ocean platforms and systems integration expertise with Mythos AI’s advanced autonomy architecture...

Continue reading

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Company delivers steady performance and achieves key milestones across critical care, pediatrics, and hospital-based outpatient therapy MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the heart and kidneys, today reported financial results for the third quarter ended September 30, 2025 and provided a business update on recent milestones advancing the company’s cardiorenal growth strategy. Third Quarter 2025 HighlightsTotal revenue of $2.2 million, down 6% year-over-year and up 29% sequentially, reflecting increased consumable utilization and stronger U.S. console sales on a sequential quarter basis. On a pro-forma basis, revenue grew approximately 7%...

Continue reading

1847 Holdings Reports 256% Revenue Growth to $13.6 Million and Achieves Profitability in Q3 2025

Gross Profit Increases 180% to $6.7 Million Revenue for the First Nine Months of 2025 Increases 326% to $36.5 Million, a $27.9 Million Increase over the Prior Year Generated $3.0 Million in Positive Cash Flow from Continuing Operations in the First Nine Months of 2025 Reaffirms 2025 Guidance for Net Income of ~$1.3 Million on Revenue of Over $45 Million; Projects 2026 Income from Operations of ~$12.0 Million on Revenue of More than $50 Million Conference Call to be Held Today at 8:30 am EST NEW YORK, NY , Nov. 12, 2025 (GLOBE NEWSWIRE) — 1847 Holdings LLC (“1847” or the “Company”) (“1847” or the “Company”) (OTCID: LBRA), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle-market businesses, today announced financial results for...

Continue reading

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering price of $1.65 per share and (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 15,151,515 shares of common stock at a public offering price of $1.649 per pre-funded warrant. The pre-funded warrants will be immediately exercisable and will have an exercise price of $0.001 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50 million. In addition, Eledon has granted to the underwriters a 30-day option to purchase up to 4,545,600 additional...

Continue reading

Rackspace Technology Unveils AI Launchpad Service – Accelerating AI Adoption and Time to Value

Enterprises Streamline AI Adoption with a Secure, Scalable Path from Experimentation to Production SAN ANTONIO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced Rackspace AI launchpad, a secure managed service designed to enable organizations to evaluate, pilot and deploy AI workloads – accelerating time to value. The service can be tailored to any industry including healthcare, banking, finance, securities and insurance (BFSI), and energy. Adoption of AI can be overwhelming, particularly when it comes to infrastructure complexity, tooling selection and performance benchmarking. Rackspace AI launchpad simplifies the journey by offering a phased, guided approach that supports every stage of AI adoption – from proof of concept to full-scale...

Continue reading

Firefly Neuroscience Reports Third Quarter 2025 Financial Results

 – Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line – – Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP scan volumes and 30% sequential revenue growth – KENMORE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today reported financial results for the three and nine months ended September 30, 2025. Business HighlightsThird quarter 2025 revenue grew more than tenfold year-over-year and 30% sequentially quarter-over-quarter, demonstrating both the immediate benefits from Firefly’s May 2025 acquisition of Evoke Neuroscience, Inc. (“Evoke”)...

Continue reading

reAlpha Tech Corp. Announces 326% Year-over-Year Revenue Growth for Quarter Ended September 30, 2025

Quarter marked continued platform expansion, AI integration, and operational progress across reAlpha’s real estate and mortgage businesses DUBLIN, Ohio, Nov. 12, 2025 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced financial results for the quarter ended September 30, 2025. Financial HighlightsRevenue increased 326% to $1,445,137 in the third quarter of 2025, compared to $339,227 in the third quarter of 2024. Cash was approximately $9.3 million as of the end of the third quarter of 2025, compared to $7.0 million as of the end of the third quarter of 2024. Gross profit was $749,580 in the third quarter of 2025, compared to $225,866 in the third quarter of 2024. The increase was primarily driven by an increase in mortgage brokerage...

Continue reading

Advanced Flower Capital Inc. Announces Financial Results for the Third Quarter 2025

Third quarter 2025 GAAP net loss of $(12.5) million or $(0.57) per basic weighted average common share and  Distributable Earnings(1) of $3.5 million or $0.16 per basic weighted average common share AFC shareholders approve conversion from mortgage REIT to BDC WEST PALM BEACH, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“Advanced Flower Capital,” “AFC,” or the “Company”) today announced its results for the quarter ended September 30, 2025. AFC reported generally accepted accounting principles (“GAAP”) net loss of $(12.5) million or $(0.57) per basic weighted average common share and Distributable Earnings of $3.5 million or $0.16 per basic weighted average common share for the third quarter of 2025. “We continue to make progress resolving our nonaccrual positions and driving loan repayments...

Continue reading

Brixton Metals Drills 112 g/t Gold Over 0.50m with Visible Gold Within 23.50m of 3.33 g/t Gold at Trapper Target

And 18.50m of 3.39 g/t Gold, Including 3.00m of 15.69 g/t Gold VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce additional drill results from the Trapper Gold Target from the 2025 season. High-grade intervals were observed, in cases accompanied by visible gold. A total of 6272m was drilled at the Trapper Target from 30 holes this season. Assays are pending for the remaining 10 holes. The zone remains open for expansion in multiple directions. This news release presents assay results for gold only, with the exception of hole THN25-360, for which partial results for other elements are included. Multi-element data will be disclosed once received. HighlightsHole THN25-360 returned 18.50m of 3.39 g/t gold, 7.45 g/t...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.